NCT03405688View on ClinicalTrials.gov

Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors

NACompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

February 13, 2018

Primary Completion Date

August 3, 2020

Study Completion Date

August 3, 2020

Conditions
Sickle Cell DiseaseSickle Cell Trait
Interventions
PROCEDURE

Blood sampling

Extra blood samples taken for laboratory analysis

Trial Locations (2)

1020

CHU Brugmann, Brussels

HUDERF, Brussels

All Listed Sponsors
lead

Hanane EL KENZ

OTHER

NCT03405688 - Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors | Biotech Hunter | Biotech Hunter